Terms: = Prostate cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Treatment
20 results:
1. Cytomorphology, immunoprofile, and clinicopathologic correlation of metastatic prostatic carcinoma.
Lin X; Shi Q; Yang XJ
Hum Pathol; 2022 Dec; 130():36-46. PubMed ID: 36244466
[TBL] [Abstract] [Full Text] [Related]
2. Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.
Lim EA; Bendell JC; Falchook GS; Bauer TM; Drake CG; Choe JH; George DJ; Karlix JL; Ulahannan S; Sachsenmeier KF; Russell DL; Moorthy G; Sidders BS; Pilling EA; Chen H; Hattersley MM; Das M; Kumar R; Pouliot GP; Patel MR
Clin Cancer Res; 2022 Nov; 28(22):4871-4884. PubMed ID: 36044531
[TBL] [Abstract] [Full Text] [Related]
3. A Rare Case of Co-Existing Mucin-Producing Urothelial-Type Adenocarcinoma of the prostate and Acinar Adenocarcinoma.
Nova-Camacho LM; Villafruela Mateos A
Int J Surg Pathol; 2023 Aug; 31(5):627-633. PubMed ID: 35903905
[TBL] [Abstract] [Full Text] [Related]
4. Oligometastatic deposits of prostate cancer found within the sigmoid pericolic fat that was resected for colonic adenocarcinoma: a case report.
Naumann DN; Hejmadi RK; Richardson JJR
J Med Case Rep; 2022 Jun; 16(1):221. PubMed ID: 35659714
[TBL] [Abstract] [Full Text] [Related]
5. Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary?
Coman R; Anract J; Pinar U; Sibony M; Peyromaure M; Delongchamps B
Int Urol Nephrol; 2022 Jul; 54(7):1485-1489. PubMed ID: 35536389
[TBL] [Abstract] [Full Text] [Related]
6. Salvage local treatment for localized radio-recurrent prostate cancer: a narrative review and future perspectives.
Büchser D; Medina R; Mayrata E; González A; Marban M; Achard V; Alongi F; Gomez-Iturriaga A; Couñago F
Future Oncol; 2021 Nov; 17(31):4207-4219. PubMed ID: 34448402
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive analysis in mucin-producing urothelial-type adenocarcinoma of the prostate: case study with literature review.
Moe K; Maa HC; Pei D; Liang YJ; Chen YL
Pol J Pathol; 2020; 71(3):244-253. PubMed ID: 33112115
[TBL] [Abstract] [Full Text] [Related]
8. Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous prostate cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
Liu W; Zhang D; Tan SA; Liu X; Lai J
Anticancer Res; 2018 Aug; 38(8):4847-4852. PubMed ID: 30061258
[TBL] [Abstract] [Full Text] [Related]
9. Skene's Glands Adenocarcinoma: A Series of 4 Cases.
Tregnago AC; Epstein JI
Am J Surg Pathol; 2018 Nov; 42(11):1513-1521. PubMed ID: 29901570
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA HULC mediates radioresistance via autophagy in prostate cancer cells.
Chen C; Wang K; Wang Q; Wang X
Braz J Med Biol Res; 2018; 51(6):e7080. PubMed ID: 29694502
[TBL] [Abstract] [Full Text] [Related]
11. Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in cancer.
Begik O; Oyken M; Cinkilli Alican T; Can T; Erson-Bensan AE
Neoplasia; 2017 Jul; 19(7):574-582. PubMed ID: 28624626
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological study of 9 cases of prostate cancer involving the rectal wall.
Tang T; Yang Z; Zhang D; Qu J; Liu G; Zhang S
Diagn Pathol; 2017 Jan; 12(1):8. PubMed ID: 28095874
[TBL] [Abstract] [Full Text] [Related]
13. [Urothelial-type mucinous adenocarcinoma of the prostate: A case report and review of the literature].
Guo YS; Gao SM; Zhang MR; Zhang JM; Zang YJ; Lu HK
Zhonghua Nan Ke Xue; 2016 Mar; 22(3):241-5. PubMed ID: 27172665
[TBL] [Abstract] [Full Text] [Related]
14. A 'One Stop' prostate Clinic for rural and remote men: a report on the first 200 patients.
McCombie SP; Hawks C; Emery JD; Hayne D
BJU Int; 2015 Oct; 116 Suppl 3():11-7. PubMed ID: 26218767
[TBL] [Abstract] [Full Text] [Related]
15. Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life.
Peters M; Maenhout M; van der Voort van Zyp JR; Moerland MA; Moman MR; Steuten LM; van Deursen MJ; van Vulpen M
Radiother Oncol; 2014 Jul; 112(1):77-82. PubMed ID: 24998704
[TBL] [Abstract] [Full Text] [Related]
16. Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the South European Uroncological Group.
Calais da Silva F; Calais da Silva FM; Gonçalves F; Santos A; Kliment J; Whelan P; Oliver T; Antoniou N; Pastidis S; Marques Queimadelos A; Robertson C
Eur Urol; 2014 Aug; 66(2):232-9. PubMed ID: 23582949
[TBL] [Abstract] [Full Text] [Related]
17. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
Lane Z; Epstein JI; Ayub S; Netto GJ
Hum Pathol; 2008 Apr; 39(4):543-9. PubMed ID: 18234278
[TBL] [Abstract] [Full Text] [Related]
18. Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer.
Bianco FJ; Wood DP; Cher ML; Powell IJ; Souza JW; Pontes JE
Clin Prostate Cancer; 2003 Mar; 1(4):242-7. PubMed ID: 15040883
[TBL] [Abstract] [Full Text] [Related]
19. A study on beams passing through hip prosthesis for pelvic radiation treatment.
Ding GX; Yu CW
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1167-75. PubMed ID: 11704342
[TBL] [Abstract] [Full Text] [Related]
20. Report on the clinical effects of inadvertent radiation underdosage in 1045 patients.
Ash D; Bates T
Clin Oncol (R Coll Radiol); 1994; 6(4):214-26. PubMed ID: 7527247
[TBL] [Abstract] [Full Text] [Related]
